The Sleep Supplement Market Is Doubling: Magnesium, GABA, and L-Theanine Reviewed

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Sleep disorders should be evaluated by a physician. Supplements interact with medications and medical conditions; consult your healthcare provider before use.

Part of our Sleep Optimization Blueprint guide.

The global sleep supplement market is projected to double in size between 2024 and 2028, according to Biohealth International’s 2026 industry analysis. Sleep problems affect roughly one-third of adults in developed countries, and as awareness of sleep’s central role in health grows — cognitive function, immune regulation, metabolic health, longevity — demand for non-pharmaceutical sleep support has accelerated. But the market is crowded with products of widely varying quality and evidence backing. This review focuses on three of the most researched non-melatonin sleep supplements: magnesium, GABA, and L-theanine.

See also: magnesium types compared

See also: melatonin dosage guide

Why Sleep Supplement Demand Is Surging

Several converging factors are driving market growth. Post-pandemic awareness of sleep’s role in immune function and mental health has elevated consumer attention. Growing concern about prescription sleep medication dependency (benzodiazepines, Z-drugs) has motivated interest in lower-risk alternatives. And a broader wellness industry shift toward “biohacking” and performance optimization has positioned sleep quality as a key variable that consumers want to actively manage.

Melatonin remains the category leader by revenue, but research concerns about its appropriateness for long-term nightly use — it’s a hormone, and chronic supplementation may affect natural production — have created space for non-hormonal alternatives.

Magnesium: The Most Researched Non-Melatonin Option

Magnesium is involved in over 300 enzymatic reactions and plays a direct role in regulating neurotransmitters and the hypothalamic-pituitary-adrenal axis — the systems most directly involved in sleep-wake cycling and stress response. Deficiency is common in Western diets: estimates suggest 40-50% of American adults consume less than the recommended daily amount.

Clinical evidence for magnesium supplementation on sleep is strongest in populations with baseline deficiency. A 2022 meta-analysis in BMC Medicine found that magnesium supplementation significantly improved subjective sleep quality, sleep efficiency, and sleep onset latency in older adults, who are more likely to be deficient and more prone to sleep difficulties.

Form matters considerably. Magnesium oxide has poor bioavailability (~4%). Magnesium glycinate (magnesium bound to glycine) and magnesium threonate (which crosses the blood-brain barrier more effectively) show better absorption and sleep-specific outcomes in clinical settings. Standard dosing for sleep is typically 200-400mg of elemental magnesium from a well-absorbed form, taken in the evening.

GABA: More Complicated Than It Appears

GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the central nervous system. Its role in reducing neuronal excitability is directly relevant to sleep — sleep onset involves a general decrease in neural activity, and GABA is central to that process. The logic of GABA supplementation is therefore intuitive: more GABA, less excitation, easier sleep onset.

The complication is the blood-brain barrier. Peripheral GABA (from supplements) was long believed not to cross the blood-brain barrier effectively in adults, which would mean that oral GABA supplementation doesn’t directly affect brain GABA levels. More recent research has complicated this picture, suggesting some GABA does cross and that peripheral GABA receptors in the gut and autonomic nervous system may independently contribute to relaxation and sleep.

Human clinical trials on GABA show modest effects on sleep onset latency and stress markers, with several Japanese studies (where GABA supplementation has a longer research history) showing 5-7 minute reductions in time to fall asleep. This is a real effect but relatively small. GABA is most credibly positioned as a relaxation supplement for those with stress-related sleep difficulties, rather than a direct sleep promoter.

L-Theanine: The Most Consistent Evidence

L-theanine, an amino acid found almost exclusively in tea leaves, is arguably the most evidence-consistent of the three compounds reviewed here. Its primary mechanism is promoting alpha-wave brain activity — the same relaxed-but-alert state associated with meditation — while reducing beta-wave activity associated with active thinking and anxiety.

Multiple randomized controlled trials have shown L-theanine (typically 100-200mg) reduces anxiety and mental arousal without sedation, improves subjective sleep quality, and reduces nighttime awakenings. A 2019 study in Nutrients found that 200mg L-theanine improved sleep satisfaction and reduced sleep disturbance and use of sleep medications in a sample of healthy adults with self-reported sleep problems.

L-theanine’s combination with low-dose magnesium glycinate is increasingly common in premium sleep formulations, with the rationale that theanine handles the mental quieting component while magnesium addresses physiological muscle relaxation and neurotransmitter support.

What the Market Growth Means for Consumers

A doubling sleep supplement market means both more good products and more noise. Several practical filters for evaluating sleep supplements:

• Third-party testing: NSF, USP, or Informed Sport certification verifies that products contain what they claim.
• Ingredient forms: Check that magnesium is glycinate or threonate, not oxide. Check that dosages match what clinical trials used.
• Realistic expectations: Even well-evidenced supplements produce modest effects. They support sleep; they don’t replace sleep hygiene fundamentals (consistent schedule, dark room, reduced blue light, no alcohol close to bedtime).

Conclusion

Magnesium, GABA, and L-theanine each have genuine evidence bases, distinct mechanisms, and appropriate use cases. None of them are magic solutions, and none substitute for addressing the underlying causes of poor sleep. But for adults with stress-related sleep difficulties or nutritional gaps, they represent a lower-risk, evidence-grounded starting point compared to pharmaceutical sleep aids.

Sources:
Biohealth International. (2026). Sleep Supplement Market Analysis 2026. biohealthinternational.com.
Zhang, Y., et al. (2022). Association of magnesium intake with sleep disorders. BMC Medicine.
Hidese, S., et al. (2019). Effects of L-theanine on sleep and anxiety. Nutrients.

Last updated: 2026-03-14